Skip to content
Recall Observatory FDA recall evidence

Drug product

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93

D-1006-2019

March 11, 2019

Class III

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 82367
Status
Terminated
Classification
Class III
Quantity
7,081 bottles
Official record key
drug-enforcement:D-1006-2019

Official wording

Reason: Subpotent Drug.

Code information: Lot #: 25Q002, Exp. 11/2019

Distribution pattern: Nationwide in the United States.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent